These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 808899)

  • 21. Total calcium content of skeletal muscle isolated from humans and pigs susceptible to malignant hyperthermia.
    Britt BA; Endrenyi L; Barclay RL; Cadman DL
    Br J Anaesth; 1975 Jun; 47(6):647-53. PubMed ID: 1148084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possible malignant hyperthermia as reaction to an overdose of myotonolytic, antidepressive and sedative drugs (author's transl)].
    Hackl JM; Engl J; Hofstädter F; Bonelli S; Rumpl E; Dworzak E; Puschendorf B
    Wien Klin Wochenschr; 1981 Aug; 93(15):475-9. PubMed ID: 6117987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central-core disease and malignant hyperpyrexia.
    Denborough MA; Dennett X; Anderson RM
    Br Med J; 1973 Feb; 1(5848):272-3. PubMed ID: 4265427
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia].
    Mehler J; Bachour H; Simons F; Wolpers K
    Anaesthesist; 1991 Sep; 40(9):497-501. PubMed ID: 1952045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ["Malignant hyperthermia" following NLA and spinal anaesthesia (author's transl)].
    Malz H; Gullotta F; Klein H; Aebert K
    Anaesthesist; 1982 May; 31(5):248-51. PubMed ID: 7103033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duchenne muscular dystrophy and malignant hyperthermia--two case reports.
    Wang JM; Stanley TH
    Can Anaesth Soc J; 1986 Jul; 33(4):492-7. PubMed ID: 3742323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant hyperthermia under general anaesthesia. Abnormal histochemical and electron-microscopic muscle findings in combination with pathological serum-CPK-values evidencing the existence of primary myopathy (author's transl)].
    Bernhardt D; Schiller H
    Anaesthesist; 1973 Aug; 22(8):367-72. PubMed ID: 4270680
    [No Abstract]   [Full Text] [Related]  

  • 28. [Report on 2 cases of malignant hyperthermia with different clinical courses].
    Menzel H; Gullotta F; Helpap B; Freiberger K
    Prakt Anaesth; 1976 Aug; 10(4):227-35. PubMed ID: 967790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suspected malignant hyperthermia in a strabismus patient. A case report.
    Dodd MJ; Phattiyakul P; Silpasuvan S
    Arch Ophthalmol; 1981 Jul; 99(7):1247-50. PubMed ID: 7259598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia in myotonia congenita.
    Heiman-Patterson T; Martino C; Rosenberg H; Fletcher J; Tahmoush A
    Neurology; 1988 May; 38(5):810-2. PubMed ID: 3362383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of myosin in nemaline myopathy.
    Sreter FA; Aström KE; Romanul FC; Young RR; Jones HR
    J Neurol Sci; 1976 Jan; 27(1):99-116. PubMed ID: 175135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases.
    Flewellen EH; Nelson TE
    Can Anaesth Soc J; 1982 Jan; 29(1):42-9. PubMed ID: 7055743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Possibilities and limitations of ultrastructural investigations in muscle diseases (author's transl)].
    Ketelsen UP
    Beitr Pathol; 1974 Jan; 151(1):1-29. PubMed ID: 4817522
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
    Glover L; Heffron JJ; Ohlendieck K
    J Appl Physiol (1985); 2004 Jan; 96(1):11-8. PubMed ID: 12959958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening tests for malignant hyperthermia susceptibility].
    Krivosic-Horber R; Adnet P
    Ann Fr Anesth Reanim; 1989; 8(5):444-56. PubMed ID: 2560612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane.
    Hildebrand SV; Howitt GA
    Am J Vet Res; 1983 Dec; 44(12):2280-4. PubMed ID: 6660617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological, histochemical and ultramicroscopic findings in muscle biopsies from carriers of the trait for malignant hyperpyrexia.
    Isaacs H; Frere G; Mitchell J
    Br J Anaesth; 1973 Aug; 45(8):860-8. PubMed ID: 4753682
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathological findings in 165 patients explored for malignant hyperthermia susceptibility.
    Figarella-Branger D; Kozak-Ribbens G; Rodet L; Aubert M; Borsarelli J; Cozzone PJ; Pellissier JF
    Neuromuscul Disord; 1993; 3(5-6):553-6. PubMed ID: 8186710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Muscle fibers of pigs sensitive to halothane and resistant to it].
    Uhrín V; Bulla J; Kulísková L; Poltársky J
    Vet Med (Praha); 1985 Apr; 30(4):217-30. PubMed ID: 3923685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.